Vascular Parkinsonism (VP) is a rare form of parkinsonism due to impairment of the central nervous system caused by damage to its blood supply. The primary symptom is tremor, which often occurs in the hands and legs, but can also affect other areas of the body. VP is caused by a variety of different conditions that block or damage small arteries, veins, or capillaries that supply the brain. This decrease in brain perfusion (blood flow) can cause a disruption of communication between neurons and, consequently, a decline in movement coordination and mobility. In addition, a decrease in dopamine, a neurochemical that helps regulate movement, may be associated with VP. Treatment of VP typically involves addressing the underlying cause, which may include anticoagulants to prevent disorders related to clot formation, or drugs to reduce inflammation and prevent clots from forming and blocking blood vessels. Physical therapy and occupational therapy, as well as drugs that increase dopamine levels, may also be used in the treatment of VP. Additionally, lifestyle modifications like stress management, exercise, and diet modification may help improve symptoms of VP. Research has shown that regular exercise can help reduce tremor and spacing out of activities may reduce the intensity of symptoms. Additionally, certain nutritional modifications like avoiding tyramines (naturally occurring amines found in some foods) may help reduce symptom severity. Overall, VP is a rare but serious disorder that can be managed with a combination of treatments. While VP may have a significant physical and psychological impact on patients, early diagnosis and a tailored treatment plan can enable patients to lead an independent and fulfilling life.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy, Australia
Title : A structure-based strategy to target pathogenic α-synuclein in Parkinson’s disease
Salvador Ventura, Autonomous University of Barcelona, Spain
Title : Rabies: Challenges in taming the beast
Alan C Jackson, University of Calgary, Canada
Title : Designing and managing intelligent and ethical transformed health and social care ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Understanding Alzheimer's disease biomarkers across diverse populations - Opportunities and Insights for novel prevision medicine approaches
Sid O Bryant, Texas College of Osteopathic Medicine and University of North Texas Health Science Center Fort Worth, United States